50-212-0768
SARS-CoV-2 Nucleocapsid Chimeric Recombinant Human Monoclonal Antibody (hIgM2003), GenScript™
Manufacturer: Genscript Corporation
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | 50-212-0768-Each-of-1 | In Stock | ₹ 36,705.24 |
50-212-0768 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 36,705.24
GST (18%): ₹ 6,606.943
Total Price: ₹ 43,312.183
Antigen
SARS-CoV-2 Nucleocapsid Chimeric
Classification
Recombinant Monoclonal
Concentration
1 mg/mL
Formulation
PBS with 0.02% sodium azide; pH 7.4
Host Species
Human
Purification Method
Affinity chromatography
Regulatory Status
RUO
Target Species
Virus
Product Type
Antibody
Isotype
IgM
Applications
ELISA
Clone
hIgM2003
Conjugate
Unconjugated
Gene Alias
Coronavirus; COVID; COVID 19; COVID19; COVID-19; SARS; SARS Coronavirus; SARS CoV; SARS CoV2; SARS CoV-2; SARS Nucleocapsid; SARS-CoV2; SARS-CoV-2
Immunogen
Recombinant SARS-CoV-2 Nucleocapsid Protein
Quantity
100 μg
Primary or Secondary
Primary
Content And Storage
-20°C
Form
Liquid
Related Products
Description
- SARS-CoV-2 (Severe acute respiratory syndrome coronavirus 2), also known as 2019-nCoV, is a positive-sense single-stranded RNA virus
- It caused coronavirus disease 2019 (COVID-19)
- Nucleocapsid Protein is a most abundant structure protein of the coronavirus which is associated with nucleic acid.SARS-CoV-2 Nucleocapsid Antibody (hIgM2003), Human Chimeric is produced from cell culture in vitro under conditions free from animal-derived components
- SARS-CoV-2 Nucleocapsid Chimeric Recombinant Monoclonal antibody specifically detects SARS-CoV-2 Nucleocapsid Chimeric in Virus samples
- It is validated for ELISA
Compare Similar Items
Show Difference
Antigen: SARS-CoV-2 Nucleocapsid Chimeric
Classification: Recombinant Monoclonal
Concentration: 1 mg/mL
Formulation: PBS with 0.02% sodium azide; pH 7.4
Host Species: Human
Purification Method: Affinity chromatography
Regulatory Status: RUO
Target Species: Virus
Product Type: Antibody
Isotype: IgM
Applications: ELISA
Clone: hIgM2003
Conjugate: Unconjugated
Gene Alias: Coronavirus; COVID; COVID 19; COVID19; COVID-19; SARS; SARS Coronavirus; SARS CoV; SARS CoV2; SARS CoV-2; SARS Nucleocapsid; SARS-CoV2; SARS-CoV-2
Immunogen: Recombinant SARS-CoV-2 Nucleocapsid Protein
Quantity: 100 μg
Primary or Secondary: Primary
Content And Storage: -20°C
Form: Liquid
Antigen:
SARS-CoV-2 Nucleocapsid Chimeric
Classification:
Recombinant Monoclonal
Concentration:
1 mg/mL
Formulation:
PBS with 0.02% sodium azide; pH 7.4
Host Species:
Human
Purification Method:
Affinity chromatography
Regulatory Status:
RUO
Target Species:
Virus
Product Type:
Antibody
Isotype:
IgM
Applications:
ELISA
Clone:
hIgM2003
Conjugate:
Unconjugated
Gene Alias:
Coronavirus; COVID; COVID 19; COVID19; COVID-19; SARS; SARS Coronavirus; SARS CoV; SARS CoV2; SARS CoV-2; SARS Nucleocapsid; SARS-CoV2; SARS-CoV-2
Immunogen:
Recombinant SARS-CoV-2 Nucleocapsid Protein
Quantity:
100 μg
Primary or Secondary:
Primary
Content And Storage:
-20°C
Form:
Liquid
Antigen: SARS-CoV-2 Spike S1 Chimeric
Classification: Recombinant Monoclonal
Concentration: 1 mg/mL
Formulation: PBS with 0.02% sodium azide; pH 7.4
Host Species: Human
Purification Method: Affinity chromatography
Regulatory Status: RUO
Target Species: Virus
Product Type: Antibody
Isotype: IgA
Applications: ELISA
Clone: hIgA2001
Conjugate: Unconjugated
Gene Alias: Coronavirus; COVID; Covid 19; COVID19; COVID-19; SARS; SARS Coronavirus; SARS CoV; SARS CoV2; SARS CoV-2; SARS Spike Protein; SARS-CoV2; SARS-CoV-2
Immunogen: Recombinant SARS-CoV-2 RBD Protein
Quantity: 100 μg
Primary or Secondary: Primary
Content And Storage: -20°C
Form: Liquid
Antigen:
SARS-CoV-2 Spike S1 Chimeric
Classification:
Recombinant Monoclonal
Concentration:
1 mg/mL
Formulation:
PBS with 0.02% sodium azide; pH 7.4
Host Species:
Human
Purification Method:
Affinity chromatography
Regulatory Status:
RUO
Target Species:
Virus
Product Type:
Antibody
Isotype:
IgA
Applications:
ELISA
Clone:
hIgA2001
Conjugate:
Unconjugated
Gene Alias:
Coronavirus; COVID; Covid 19; COVID19; COVID-19; SARS; SARS Coronavirus; SARS CoV; SARS CoV2; SARS CoV-2; SARS Spike Protein; SARS-CoV2; SARS-CoV-2
Immunogen:
Recombinant SARS-CoV-2 RBD Protein
Quantity:
100 μg
Primary or Secondary:
Primary
Content And Storage:
-20°C
Form:
Liquid
Antigen: __
Classification: __
Concentration: __
Formulation: __
Host Species: __
Purification Method: __
Regulatory Status: __
Target Species: __
Product Type: __
Isotype: __
Applications: __
Clone: __
Conjugate: __
Gene Alias: __
Immunogen: __
Quantity: __
Primary or Secondary: __
Content And Storage: __
Form: __
Antigen:
__
Classification:
__
Concentration:
__
Formulation:
__
Host Species:
__
Purification Method:
__
Regulatory Status:
__
Target Species:
__
Product Type:
__
Isotype:
__
Applications:
__
Clone:
__
Conjugate:
__
Gene Alias:
__
Immunogen:
__
Quantity:
__
Primary or Secondary:
__
Content And Storage:
__
Form:
__
Antigen: __
Classification: __
Concentration: __
Formulation: __
Host Species: __
Purification Method: __
Regulatory Status: __
Target Species: __
Product Type: __
Isotype: __
Applications: __
Clone: __
Conjugate: __
Gene Alias: __
Immunogen: __
Quantity: __
Primary or Secondary: __
Content And Storage: __
Form: __
Antigen:
__
Classification:
__
Concentration:
__
Formulation:
__
Host Species:
__
Purification Method:
__
Regulatory Status:
__
Target Species:
__
Product Type:
__
Isotype:
__
Applications:
__
Clone:
__
Conjugate:
__
Gene Alias:
__
Immunogen:
__
Quantity:
__
Primary or Secondary:
__
Content And Storage:
__
Form:
__